- Home
- GH vs GLPI Comparison
GH vs GLPI Comparison
Compare GH & GLPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GH | GLPI |
|---|---|---|
| Founded | 2011 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.3B | 13.9B |
| IPO Year | 2018 | 2013 |
Fundamental Metrics
Financial Performance| Metric | GH | GLPI |
|---|---|---|
| Price | $85.12 | $45.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 20 | 12 |
| Target Price | ★ $117.80 | $52.13 |
| AVG Volume (30 Days) | 1.7M | ★ 2.0M |
| Earning Date | 04-29-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 6.62% |
| EPS Growth | ★ 6.74 | 2.79 |
| EPS | N/A | ★ 2.95 |
| Revenue | $982,021,000.00 | ★ $1,594,752,000.00 |
| Revenue This Year | $33.40 | $8.04 |
| Revenue Next Year | $28.55 | $4.88 |
| P/E Ratio | ★ N/A | $15.98 |
| Revenue Growth | ★ 32.88 | 4.13 |
| 52 Week Low | $36.36 | $41.17 |
| 52 Week High | $120.74 | $51.44 |
Technical Indicators
Market Signals| Indicator | GH | GLPI |
|---|---|---|
| Relative Strength Index (RSI) | 34.90 | 37.42 |
| Support Level | $82.26 | $45.54 |
| Resistance Level | $103.16 | $47.20 |
| Average True Range (ATR) | 3.94 | 0.88 |
| MACD | 0.07 | -0.39 |
| Stochastic Oscillator | 20.02 | 8.85 |
Price Performance
Historical ComparisonAbout GH Guardant Health Inc.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About GLPI Gaming and Leisure Properties Inc.
Gaming and Leisure Properties Inc, or GLP, is a self-administered and self-managed Pennsylvania real estate investment trust (REIT). It is engaged in acquiring, financing, and owning real estate property to be leased to gaming operators in triple-net lease arrangements. The company also extends loans that produce fixed or variable returns, which may convert into leased rent upon project completion or stabilization. Its portfolio consists of gaming and related facilities and amenities such as Ameristar Black Hawk, Bally's Casino, Argosy Casino Alton, Bally's Chicago, Hollywood Casino Aurora, and others located across different states in the United States.